Prevalence and correlates of the insulin resistance syndrome among Native Americans: The Inter-Tribal Heart Project

Diabetes Care

Volumn 22, Issue 3, 1999, Pages 441-447

  Greenlund, Kurt J ^a,b   Valdez, Rodolfo ^b   Casper, Michele L ^a   Rith Najarian, Stephen ^c   Croft, Janet B ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c INDIAN HEALTH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AMERICAN INDIAN; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CLUSTER ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; RISK FACTOR; UNITED STATES;

EID: 0032974877     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.3.441     Document Type: Article

References (39)

1. Reaven GM: Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
2. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP: Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41:715-722, 1992
3. Stern MP: Diabetes and cardiovascular disease: the "common soil" hypothesis. Diabetes 44:369-374, 1995
4. Zimmet PZ, McCarty DJ, de Courten MP: The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome. J Diabetes Complications 11:60-68, 1997
5. Schmidt MI, Duncan BB, Watson RL, Sharrett AR, Brancati FL, Heiss G: A metabolic syndrome in whites and African-Americans: the Atherosclerosis Risk in Communities baseline study. Diabetes Care 19:414-418, 1996
6. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and other atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
7. Ferrannini E, Haffner SM, Mitchell BD, Stem MP: Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34:416-422, 1991
8. Indian Health Service: Regional Differences in Indian Health. Rockville, MD, U.S. Department of Health and Human Services, Indian Health Service, Office of Planning Evaluation and Legislation, 1996
9. Knowler WC, Bennett PH, Hamman RF, Miller M: Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incident that in Rochester, Minnesota. Am J Epidemiol 108:497-505, 1978
10. Campos-Outcalt D, Ellis J, Aickin M, Valencia J, Wunsch M, Steele L: Prevalence of cardiovascular disease risk factors in a southwestern Native American tribe. Public Health Rep 110:742-748, 1995
11. Ellis JL, Campos-Outcalt D: Cardiovascular disease risk factors in Native Americans: a literature renew. Am J Prev Med 10:295-307, 1994
12. DeLisle HF, Rivard M, Ekoe JM: Prevalence estimates of diabetes and of other cardiovascular risk factors in the two largest Algonquin communities of Quebec. Diabetes Care 18:1255-1259, 1991
13. Casper M, Rith-Najarian S, Croft J, Giles W, Donehoo R: Blood pressure, diabetes, and body mass index among Chippewa and Menominee Indians: the Inter-Tribal Heart Project preliminary data. Public Health Rep 111:37-39, 1996
14. Centers for Disease Control and Prevention: Inter-Tribal Health Project: Results From the Cardiovascular Health Survey. Atlanta, GA, Centers for Disease Control and Prevention, 1996
15. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-501, 1972
16. National Cholesterol Education Program: Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Bethesda, MD, National Heart, Lung and Blood Institute, 1993 (NIH publ. no. 93-3095)
17. Consensus Conference: Treatment of hypertriglyceridemia. JAMA 251:1196-1200, 1984
18. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
19. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNCV). Arch Intern Med 153:154-183, 1993
20. Valdez R: A simple model-based index of abdominal adiposity. J Clin Epidemiol 44: 955-956, 1991
21. Haffner SM, Miettinen H: Insulin resistance implications for type II diabetes mellitus and coronary heart disease. Am J Med 103:152-162, 1997
22. Laakso M: How good a marker is insulin level for insulin resistance? Am J Epidemiol 137:959-965, 1993
23. Wingard DL, Barrett-Connor E: Heart disease and diabetes. In Diabetes in America. 2nd ed. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995, p. 429-448 (NIH publ. no. 95-1468)
24. Ruige JB, Assendelft WJJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM: Insulin and risk of cardiovascular disease: a meta-analysis. Circulation 97:996-1001, 1998
25. Burchfiel CM, Abbott RD, Curb JD, Sharp DS, Rodriguez BL, Arakaki R, Yano K: Association of insulin levels with lipids and lipoproteins in elderly Japanese-American men. Ann Epidemiol 8:92-98, 1998
26. Burchfiel CM, Sharp DS, Curb JD, Rodriguez BL, Abbott RD, Arakaki R, Yano K: Hyperinsulinemia and cardiovascular disease in elderly men: the Honolulu Heart Program. Arterioscler Thromb Vasc Biol 18:450-457, 1998
27. Reaven GM, Chen YDI, Jeppesen J, Maheux P, Krauss RM: Insulin resistance and hyperinsulinemia in individuals with small dense, low density lipoprotein particles. J Clin Invest 92:141-146, 1993
28. Haffner SM, Mykkänen L, Paidi M, Valdez R, Howard BV, Stern MP: Small dense LDL is associated with the insulin resistance syndrome. Diabetologia 38:1328-1336, 1995
29. Reaven GM: Are insulin resistance and/or compensatory hyperinsulinemia involved in the etiology and clinical course of patients with hypertension? Int J Obes Relat Metab Disord 19 (Suppl. 1):2-5, 1995
30. Jarrett RJ: In defence of insulin: a critique of syndrome X. Lancet 340:469-471, 1992
31. Meigs JB, D'Agostino RB Sr, Wilson PWF, Cupples LA, Nathan DM, Singer DE: Risk variable clustering in the insulin resistance syndrome. Diabetes 46:1594-1600, 1997
32. Edwards KL, Austin MA, Newman B, Mayer E, Krauss RM, Selby JV: Multivariate analysis of the insulin resistance syndrome in women. Arterioscler Thromb Vasc Biol 14:1940-1945, 1994
33. Saad MF, Lillioja S, Nyomba BL, Castillo C, Ferraro R, De Gregorio M, Ravussin E, Knowler WC, Bennett PH, Howard BV, Bogardus C: Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 324:733-739, 1991
34. Falkner B, Kushner H, Tulenko T, Aumner AE, Marsh JB: Insulin sensitivity lipids, and blood pressure in young American blacks. Arterioscler Thromb Vasc Biol 15:1798-1804, 1995
35. Zimmet PZ, Collins VR, Dowse GK, Alberti KGMM, Tuomilehto J, Knight LT, Gareeboo H, Chitson P, Fareed D: Is hyperinsulinaemia a central characteristic of a chronic cardiovascular risk factor clustering syndrome? Mixed findings in Asian Indian, Creole and Chinese Mauritians. Diabet Med 11:388-396, 1994
36. Pi-Sunyer FX: Medical hazards of obesity. Ann Intern Med 119:655-660, 1993
37. Howard BV, Lee ET, Yeh JL, Go O, Fabsitz R, Devereaux RB, Welty TK: Hypertension in adult American Indians: the Strong Heart Study. Hypertension 28:256-264, 1996
38. Ferrannini E, Natali A, Capaldo B, Lehtovirta M, Jacob S, Yki-Järvinen H: Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. Hypertension 30:1144-1149, 1997
39. Knowler WC, Saad MF, Pettitt DJ, Nelson RG, Bennett PH: Determinants of diabetes mellitus in the Pima Indians. Diabetes Care 16 (Suppl. 1):216-227, 1993